Opana Related Clinical Trials
Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions [Completed]
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects [Terminated]
Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin) [Completed]
Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions [Completed]
Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions [Completed]
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects [Recruiting]
Effect of Extended-release Oxymorphone Taking With or Without Food on Cognitive Functioning [Completed]
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone [Recruiting]
Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects. [Completed]
Lumbar Stenosis Outcomes Research II [Completed]
A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation) [Completed]
Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain [Completed]
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain [Completed]
Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy [Completed]
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects [Withdrawn]
Post-operative Efficacy and Safety Study [Completed]
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain [Completed]
Open Label Assessment of Long-Term Safety and Utility [Completed]
A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users [Completed]
A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted [Completed]
Pharmacokinetics Study of ALO-02 and OxyContin [Completed]
Predicting Oxycodone Dose From Oral Fluid Drug Levels [Completed]
A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers [Completed]
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients [Recruiting]
|
